• Latest Posts

This Immunotherapy Could Be The First to Treat Milk Allergy in Children

Positive House Dust Mite Immunotherapy Results for UK Biotech

Grass Pollen Allergy Vaccine Gets Encouraging Phase II Results

DBV Technologies’ Milk Allergy Patch Helps Kids in a Phase II Trial

ASIT Biotech Raises €13.9 M to Develop Allergy Immunotherapies

After Failed Trial, French Biotech Gets Good News for its Peanut Allergy Therapy


Peanut Allergy Trial Fails but French Biotech Keeps Pushing for Approval

British Rapid Action Allergy Vaccine Gets Approval for Phase II Trial

French Biotech May Save Toddlers from Life-Threatening Peanut Allergy

Circassia Freezes its Allergy Portfolio after a Second Failed Clinical Trial

Suffering from House Dust Mite Allergy? A New Therapy is on its Way

Germany gains Strength in Allergy Immunotherapeutics